Spero Therapeutics Inc Sustainability Reports
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for multi-drug resistant bacterial infections and rare diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930074G13LHWJT2323
FIGI: BBG00HXSJ1S1
9 reports from 2017 to 2025